Jump to content

Kim L. O'Neill

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by KasparBot (talk | contribs) at 05:39, 20 April 2016 (migrating Persondata to Wikidata, please help, see challenges for this article). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.

O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a professor of microbiology at Brigham Young University.

O'Neill is also a convert to The Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland.

Sources